Transgenic circulating endothelial cells

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61L 27/38 (2006.01) A61L 31/00 (2006.01) A61P 7/04 (2006.01) C07K 14/755 (2006.01) C12N 5/10 (2006.01) C12Q 1/02 (2006.01) A61K 35/12 (2006.01) C12N 5/06 (2006.01) C12N 5/08 (2006.01)

Patent

CA 2351671

A process is provided for expanding the population of endothelial cells obtained from peripheral blood which can be transformed with a vector comprising a DNA sequence encoding a preselected bioactive polypeptide. The resulting transgenic endothelial cells are useful to biocompatibilize implantable medical devices or can be used directly, as for gene therapy.

L'invention concerne un procédé permettant d'accroître la population de cellules endothéliales du sang périphérique, ces cellules pouvant être transformées à l'aide d'un vecteur renfermant une séquence d'ADN codant pour un polypeptide bioactif prédéfini. Les cellules endothéliales transgéniques ainsi obtenues sont notamment utiles pour rendre biocompatibles des dispositifs médicaux implantables, ou peuvent être utilisées directement, par exemple en thérapie génique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Transgenic circulating endothelial cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transgenic circulating endothelial cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic circulating endothelial cells will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1840369

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.